<SEC-DOCUMENT>0000950170-25-067452.txt : 20250509
<SEC-HEADER>0000950170-25-067452.hdr.sgml : 20250509
<ACCEPTANCE-DATETIME>20250508203009
ACCESSION NUMBER:		0000950170-25-067452
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20250509
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250509
DATE AS OF CHANGE:		20250508

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GYRE THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001124105
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				562020050
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51173
		FILM NUMBER:		25928081

	BUSINESS ADDRESS:	
		STREET 1:		12770 HIGH BLUFF DRIVE, SUITE 150
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		(619) 949-3681

	MAIL ADDRESS:	
		STREET 1:		12770 HIGH BLUFF DRIVE, SUITE 150
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CATALYST BIOSCIENCES, INC.
		DATE OF NAME CHANGE:	20150820

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TARGACEPT INC
		DATE OF NAME CHANGE:	20000919
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>gyre-20250509.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-05-08T17:47:50.2167+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:gyre="http://www.gyretx.com/20250509" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:utr="http://www.xbrl.org/2009/utr">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;position:relative;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_408bd495-aed1-4cdc-9f01-7c772fba48c6" name="dei:EntityCentralIndexKey" contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8">0001124105</ix:nonNumeric><ix:nonNumeric id="F_5b0fd738-f774-4f82-9278-c40bd29ab481" name="dei:AmendmentFlag" contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8" format="ixt:fixed-false">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="gyre-20250509.xsd"/></ix:references><ix:resources><xbrli:context id="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124105</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-05-09</xbrli:startDate><xbrli:endDate>2025-05-09</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid #ffffff;text-align:center;"><span style="white-space:pre-wrap;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="border-top:2.25pt double;padding-top:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="border-top:0.75pt solid;padding-top:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6802a9a5-28d5-4388-bfd6-423bf670d6c8" contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8-K</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="border-top:0.75pt solid;padding-top:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CURRENT REPORT</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Date of report (Date of earliest event reported): </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_02eb8609-ad8b-43c5-8d4a-e6752afe031b" contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">May 9, 2025</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:22pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f88903b5-5d31-476f-8ba6-5e291b591e93" contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:22pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Gyre Therapeutics, Inc.</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Exact name of registrant as specified in its charter)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:33%;box-sizing:content-box;"/>
     <td style="width:34%;box-sizing:content-box;"/>
     <td style="width:33%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_d61d0191-d9bc-48e7-8470-7b00f11d11ad" contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_e3e31129-b729-4d63-8e95-848547b85274" contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">000-51173</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_5f3f5439-f7ae-4f70-be5c-de92c5a407e2" contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">56-2020050</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(State or other jurisdiction of incorporation)</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Commission File Number)</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(IRS Employer Identification No.)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:49%;box-sizing:content-box;"/>
     <td style="width:2%;box-sizing:content-box;"/>
     <td style="width:49%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_790e36d5-2387-46f2-b99c-eeb9cec19f33" contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">12770 High Bluff Drive</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_2f5e3a25-b103-4df9-810b-e751c7946955" contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8" name="dei:EntityAddressAddressLine2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Suite 150</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_129d2718-6ad8-4a68-ac1e-61a58dd7cbde" contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">San Diego</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_51746b77-19b4-4118-80d8-d678c57d4504" contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8" name="dei:EntityAddressStateOrProvince"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">CA</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_ec73bce0-ff2b-47dd-8892-70d81a0df8ba" contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">92130</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Address of principal executive offices)</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Zip Code)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Registrant&#8217;s telephone number, including area code: </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b6be4f22-475f-453f-85de-198a80ac72aa" contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">858</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0ac9ebe2-12b4-49ae-bb3c-cb9ee1d741b5" contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">567-7770</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">N/A</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Former name or former address, if changed since last report)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">see</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> General Instruction A.2. below):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:5%;box-sizing:content-box;"/>
     <td style="width:95%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_9230b81d-b476-4394-af20-0824faf1034c" contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:5%;box-sizing:content-box;"/>
     <td style="width:95%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_37c18f17-1973-4170-8d3a-47bc29acb22f" contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:5%;box-sizing:content-box;"/>
     <td style="width:95%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_2221bb99-9c1c-4440-b287-a8fee03354ee" contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:5%;box-sizing:content-box;"/>
     <td style="width:95%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_a4d1ec79-eed7-4155-b92f-cdfc677c0460" contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:35%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:24.62%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:38.38%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Title of each class</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Trading Symbol(s)</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name of each exchange on which</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">registered</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_da8708c9-9c69-4716-9fea-7ae3079fa6c6" contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common Stock</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_c44f9a91-bec7-4081-b25d-4d959a1bc0d6" contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">GYRE</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">The </span><span><ix:nonNumeric id="F_8da4383c-0893-431d-ac59-52d87f260bfd" contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Nasdaq</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Capital Market</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Emerging growth company </span><span style="font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_c849c9ef-5695-40ca-8061-b371c8a2a332" contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:4pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="border-top:2.25pt double;padding-top:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:4pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid #ffffff;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 2.02.    Results of Operations and Financial Condition.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 9, 2025, Gyre Therapeutics, Inc. issued a press release announcing its financial results for the three months ended March 31, 2025 and other matters described. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">As provided in General Instruction B.2 of Form 8-K, the information in this Item 2.02 and Exhibit 99.1 incorporated herein shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) or otherwise subject to the liabilities of that section, nor shall such information or Exhibit 99.1 be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9.01.    Financial Statements and Exhibits.</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d) </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exhibits</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The following exhibits are being furnished herewith:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:10%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:89%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit Number</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit Title or Description</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="gyre-ex99_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Press Release, dated May 9, 2025</span></a></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:5.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNATURE</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:50.16%;box-sizing:content-box;"/>
     <td style="width:6%;box-sizing:content-box;"/>
     <td style="width:43.84%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">GYRE THERAPEUTICS, INC.</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date:</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#160;May 9, 2025</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Han Ying, Ph.D.</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Han Ying, Ph.D.</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Title:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Executive Officer</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>gyre-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;position:relative;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#181818;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 99.1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><img src="img51893664_0.jpg" alt="img51893664_0.jpg" style="width:206px;height:43px;"></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Gyre Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">Net Income of $3.7 million; reaffirms Full-Year Revenue Guidance of $118&#x2013;$128 million</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri Light',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">Q1 2025 revenue of $22.1 million; GAAP basic EPS: $0.03  </font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri Light',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">Completed data collection and achieved database lock for the pivotal Phase 3 trial of Hydronidone in Chronic Hepatitis B (&#x201c;CHB&#x201d;)-associated liver fibrosis; currently reviewing data and on track to report topline results in Q2 2025</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri Light',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">Received IND approval from China&#x2019;s National Medical Products Administration (&#x201c;NMPA&#x201d;) for a new indication of pirfenidone to treat radiation-induced lung injury (&#x201c;RILI&#x201d;), with or without immune-related pneumonitis (&#x201c;CIP&#x201d;), marking Gyre&#x2019;s first entry into oncology supportive care space</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri Light',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">Initiated commercialization of avatrombopag in China in March 2025, building a strategic presence with liver disease specialists</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri Light',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">Nintedanib remains on track for commercialization in May 2025, expanding IPF treatment options across our physician network</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri Light',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">$51.3 million in cash, cash equivalents, and short and long-term deposits as of March 31, 2025</font></div></div><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri Light',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">SAN DIEGO, May 9, 2025 (GLOBE NEWSWIRE) &#x2013; Gyre Therapeutics (&#x201c;Gyre&#x201d;) (Nasdaq: GYRE), an innovative, commercial-stage biotechnology company focused on organ fibrosis, today announced financial results for the first quarter ended March 31, 2025 and provided a business update.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201c;This quarter marked a meaningful step forward in expanding our market presence, particularly in the liver space,&#x201d; said Han Ying, Ph.D., CEO of Gyre Therapeutics. &#x201c;The successful launch of avatrombopag and our growing commercial footprint with hepatology and hematology specialists provide a strong foundation for our future growth. In addition, the recent NMPA approval to initiate a clinical trial of pirfenidone in radiation-induced lung injury, including with or without immune-related pneumonitis, supports our ability to enter the oncology supportive care space with a novel, lung-protective therapy. We plan to initiate an adaptive Phase 2/3 trial in the second half of 2025 to advance this program through development.&#x201d;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">First Quarter 2025 Business Highlights and Upcoming Milestones</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">Commercial Portfolio Expansion</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">ETUARY&#174; (pirfenidone):</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> Delivered $21.7 million in Q1 sales. While sales declined year-over-year due to relatively high sales in the first quarter of 2024, ETUARY remains the market leader for idiopathic pulmonary fibrosis (IPF) in the PRC.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">1</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Nintedanib</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">: Gyre remains on track to commercially launch nintedanib in May 2025, targeting multiple forms of fibrosing interstitial lung disease (&#x201c;ILD&#x201d;), including IPF, systemic sclerosis-associated ILD, and progressive fibrosing ILD. This is expected to expand Gyre&#x2019;s share of the pulmonary fibrosis treatment landscape and support second-half 2025 revenue growth.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Avatrombopag</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">: Commercialization of avatrombopag was initiated in March 2025, expanding Gyre&#x2019;s footprint in hepatology and hematology. Approved for thrombocytopenia in adults with chronic liver disease and immune thrombocytopenic purpura, the launch aligns with Gyre&#x2019;s strategy to deepen clinical engagement with liver disease specialists and diversify the market of available products.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">Indication Expansion: Oncology Supportive Care</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Pirfenidone New Indication</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">: In March 2025, Gyre received NMPA approval to initiate a clinical trial of pirfenidone for RILI, including cases complicated by CIP. This development positions pirfenidone for potential entry into oncology supportive care, with plans to begin an adaptive Phase 2/3 trial in the second half of 2025 across top oncology centers in China.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">Pipeline Development Updates</font></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">F573:</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">F573 is a caspase inhibitor and potential Category 1 new drug for the treatment of acute/acute on-chronic liver failure (&#x201c;ALF/ACLF&#x201d;). Completion of the Phase 2 clinical trial of F573 for ALF/ACLF is expected by the end of 2026.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">F230:</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">F230, a selective endothelin receptor agonist for the treatment of pulmonary arterial hypertension (&#x201c;PAH&#x201d;), is expected to begin a Phase 1 trial in Q2 2025.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">F528:</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">F528, a novel anti-inflammation agent with the potential to modify the progression of chronic obstructive pulmonary disease (&#x201c;COPD&#x201d;), is undergoing preclinical studies as a potential first-line therapy for the treatment of COPD. Gyre Pharmaceuticals plans to submit an IND application in 2026. </font></div></div><p style="text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">Corporate Updates</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">In March 2025, Gyre appointed Ping Zhang as Executive Chairman of the Company&#x2019;s Board of Directors; he remains a member of the Nominating and Corporate Governance Committee.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Financial Results</font></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">Cash Position</font></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">As of March 31, 2025, Gyre Therapeutics held $15.0 million in cash and cash equivalents, $14.8 million in short-term bank deposits, and $21.4 million in long-term certificates of deposit, totaling $51.3 million.</font></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Gyre believes that its existing cash resources, combined with anticipated cash flow from commercial operations, will be sufficient to fund its operating and capital requirements for the next 12 months.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">2</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">Financial Results for the Three Months Ended March 31, 2025</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Revenues: </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Revenues for the three months ended March 31, 2025, were $22.1 million, compared to $27.2 million in the same period last year. The $5.1 million decrease was primarily due to a $5.2 million decline in ETUARY&#174; sales. This was anticipated, as early 2024 revenues were elevated by a one-time marketing campaign focused on rural expansion, which we did not repeat in 2025. The shift in marketing resources was deliberate, with funds reallocated to support the upcoming launches of Nintedanib and avatrombopag. Additionally, weaker economic conditions in China and increased competition in the IPF treatment market also contributed to the decline. Revenues from generic products decreased by $0.2 million, partially offset by $0.3 million in initial revenue from the March 2025 launch of avatrombopag.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Gyre anticipates revenue growth over the remainder of the year, driven by the planned commercial launch of Nintedanib in May 2025 and the continued expansion of avatrombopag. Based on current performance and market outlook,</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">the company is reaffirming its full-year 2025 revenue guidance of $118 to $128 million</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">1</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">, compared to $105.8 million in 2024.</font></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Cost of Revenues:</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> For the three months ended March 31, 2025, cost of revenues was $0.9 million, compared to $1.0 million for the same period in 2024. The $0.1 million decrease was in line with the corresponding decline in sales.</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Selling &amp; Marketing Expense</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">: For the three months ended March 31, 2025, selling and marketing expense was $10.8 million, compared to $12.5 million for the same period in 2024. The $1.7 million decrease was primarily driven by a reduction in commission costs due to the decrease of sales.</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Research &amp; Development Expense: </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">For the three months ended March 31, 2025, research and development expense was $3.1 million, compared to $2.2 million for the same period in 2024. The increase was primarily attributable to Gyre Pharmaceuticals and was driven by a $1.3 million increase in clinical research expenses, primarily related to data analysis costs for F351. This increase was partially offset by a $0.2 million decrease in materials and utilities and a $0.1 million reduction in staff costs, primarily due to reduction of headcounts. The overall increase was further offset by a $0.1 million decrease from Gyre Therapeutics, due to the reduction in contract services.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">[1] 2025 revenue guidance assumes a constant foreign currency exchange rate and no significant economic disruption or downturn.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">3</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">General &amp; Administrative Expense: </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">For the three months ended March 31, 2025, general and administrative expense was $5.0 million, compared to $3.4 million for the same period in 2024. The increase was primarily driven by a $0.6 million increase in functional and administrative department's personnel and stock compensation costs, a $0.8 million increase in miscellaneous expense, mainly due to the increase in the annual meeting expense.</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Income from operations:</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> For the three months ended March 31, 2025, income from operations was $2.3 million, compared to $8.1 million for the same period in 2024. The decrease was primarily due to a reduction in revenue. </font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Net Income: </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">For the three months ended March 31, 2025, net income was $3.7 million, compared to $9.9 million in net income for the same period in 2024. The decrease was primarily attributable to lower income from operations and unfavorable change in fair value of warrant liabilities. </font></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Non-GAAP Adjusted Net Income:</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> For the three months ended March 31, 2025, non-GAAP adjusted net income was $2.9 million, compared to $8.2 million non-GAAP adjusted net income for the same period in 2024. The decrease was primarily driven by the decline in revenue of $5.1 million and </font><font style="color:#000000;white-space:pre-wrap;font-size:11.5pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">increase in operating expenses of $0.2 million.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Use of Non-GAAP Financial Measures by Gyre Therapeutics, Inc.</font></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Gyre reports financial results in accordance with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;). This release presents the financial measure &#x201c;adjusted net income,&#x201d; which is not calculated in accordance with GAAP. The most directly comparable GAAP measure for this non-GAAP financial measure is &#x201c;net income.&#x201d; Adjusted net income presents Gyre&#x2019;s results of operations after excluding gain from change in fair value of warrants, stock-based compensation, and provision for income taxes. This is meant to supplement, and not substitute, Gyre&#x2019;s financial information presented in accordance with GAAP. Adjusted net income as defined by Gyre may not be comparable to similar non-GAAP measures presented by other companies. Management believes that presenting adjusted net income provides investors with additional useful information in evaluating the Gyre&#x2019;s performance and valuation. See the reconciliation of adjusted net income to net income in the section titled &#x201c;Reconciliation of GAAP to Non-GAAP Financial Measures&#x201d; below.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">About F351 (Hydronidone)</font></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">F351 is a structural analogue of the approved anti-fibrotic IPF drug pirfenidone and has been shown to inhibit in vitro both p38&#x3b3; kinase activity and TGF-&#x3b2;1-induced excessive collagen synthesis in hepatic stellate cells (&#x201c;HSCs&#x201d;), which are recognized as critical event in the development and progression of fibrosis in the liver. This is further supported by its anti-proliferative effects on the HSCs in the liver. In vitro anti-fibrotic effects of F351 were also confirmed in several established in vivo models of liver fibrosis such as CCI4-induced liver fibrosis mouse model, DMN-induced liver fibrosis rat model, and HSA-induced liver rat model, as well as mouse model of MASH fibrosis (CCI4+Western High Fat Diet).</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">About Gyre Pharmaceuticals</font></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Gyre Pharmaceuticals is a commercial-stage biopharmaceutical company committed to the research, development, manufacturing and commercialization of innovative drugs for organ fibrosis. Its flagship</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">4</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">product, ETUARY&#174; (pirfenidone capsule), was the first approved treatment for IPF in the PRC in 2011 and has maintained a prominent market share (2024 net sales of $105.8 million). In addition, Gyre Pharmaceuticals is evaluating F351 in a Phase 3 clinical trial in CHB-associated liver fibrosis in the PRC, which is expected to report topline data by Q2 2025. F351 received Breakthrough Therapy designation by the NMPA Center for Drug Evaluation in March 2021. Gyre Pharmaceuticals is also developing treatments for PD, DKD, RILI with or without immune-related pneumonitis, COPD, PAH and ALF/ACLF. In October 2023, Gyre Therapeutics acquired an indirect majority interest in Gyre Pharmaceuticals (also known as Beijing Continent Pharmaceuticals Co., Ltd.).</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">About Gyre Therapeutics</font></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Gyre Therapeutics is a biopharmaceutical company headquartered in San Diego, CA, with a primary focus on the development and commercialization of F351 (Hydronidone) for the treatment of MASH-associated fibrosis in the U.S. Gyre&#x2019;s development strategy for F351 in MASH is based on the company's experience in MASH rodent model mechanistic studies and CHB-induced liver fibrosis clinical studies. Gyre is also advancing a diverse pipeline in the PRC through its indirect controlling interest in Gyre Pharmaceuticals, including ETUARY therapeutic expansions, F573, F528, and F230.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">5</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Forward-Looking Statements</font></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">This press release contains &#x201c;forward-looking statements&#x201d; within the meaning of the &#x201c;safe harbor&#x201d; provisions of the Private Securities Litigation Reform Act of 1995, which statements are subject to substantial risks and uncertainties and are based on estimates and assumptions. All statements, other than statements of historical facts included in this press release, are forward-looking statements, including statements concerning: the expectations regarding Gyre&#x2019;s research and development efforts, timing of expected clinical readouts, including topline results of the Phase 3 trial of Hydronidone in CHB-associated liver fibrosis, timing of initiation of Gyre&#x2019;s Phase 2 trial in the U.S. for F351 for the treatment of MASH-associated liver fibrosis, initiation of Gyre Pharmaceuticals&#x2019; clinical trial evaluating pirfenidone capsules in oncology-related pulmonary complications, timing of completion of Gyre&#x2019;s Phase 2 clinical trial in the PRC of F573 for ALF/ACLF, initiation of Phase 1 trial of F230 for the treatment of PAH and IND submission of F528 in COPD, the expectations regarding commercial launch of nintedanib, interactions with regulators, expectations regarding future product sales, and Gyre&#x2019;s financial position and cash resources. In some cases, you can identify forward-looking statements by terms such as &#x201c;may,&#x201d; &#x201c;might,&#x201d; &#x201c;will,&#x201d; &#x201c;objective,&#x201d; &#x201c;intend,&#x201d; &#x201c;should,&#x201d; &#x201c;could,&#x201d; &#x201c;can,&#x201d; &#x201c;would,&#x201d; &#x201c;expect,&#x201d; &#x201c;believe,&#x201d; &#x201c;design,&#x201d; &#x201c;estimate,&#x201d; &#x201c;predict,&#x201d; &#x201c;potential,&#x201d; &#x201c;plan&#x201d; or the negative of these terms, and similar expressions intended to identify forward-looking statements. These statements reflect our plans, estimates, and expectations, as of the date of this press release. These statements involve known and unknown risks, uncertainties and other factors that could cause our actual results to differ materially from the forward-looking statements expressed or implied in this press release. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation: Gyre&#x2019;s ability to execute on its clinical development strategies; positive results from a clinical trial may not necessarily be predictive of the results of future or ongoing clinical trials; the timing or likelihood of regulatory filings and approvals; competition from competing products; the impact of general economic, health, industrial or political conditions in the United States or internationally; the sufficiency of Gyre&#x2019;s capital resources and its ability to raise additional capital. Additional risks and factors are identified under &#x201c;Risk Factors&#x201d; in Gyre&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2024 filed on March 17, 2025 and in other filings with the Securities and Exchange Commission.</font></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Gyre expressly disclaims any obligation to update any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">For Investors:</font></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Stephen Jasper</font></p><p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">stephen@gilmartinir.com</font></font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">6</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Gyre Therapeutics, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Condensed Consolidated Statements of Operations</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(In thousands, except share and per share amounts)</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(Unaudited)</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:99.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:66.586%;box-sizing:content-box;"></td>
     <td style="width:1.293%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:13.414%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:1.475%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:13.232%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Three Months Ended March 31,</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">2025</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">2024</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Revenues</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">22,058</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">27,172</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Operating expenses:</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Cost of revenues</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">894</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">979</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Selling and marketing</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">10,841</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">12,542</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Research and development</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">3,095</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">2,182</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">General and administrative</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">4,955</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">3,398</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Total operating expenses</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">19,785</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">19,101</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Income from operations</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">2,273</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">8,071</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Other income, net:</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Other income, net</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">107</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">122</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Change in fair value of warrant liability</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">2,255</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">4,288</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Income before income taxes</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">4,635</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">12,481</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Provision for income taxes</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(901</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(2,546</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Net income</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">3,734</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">9,935</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Net income attributable to noncontrolling interest</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">1,036</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">2,403</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Net income attributable to common stockholders</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">2,698</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">7,532</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Net income per share attributable to common stockholders:</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Basic</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">0.03</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">0.09</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Diluted</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">0.00</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">0.03</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Weighted average shares used in calculating net income per share attributable to common stockholders:</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Basic</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">86,420,530</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">83,265,879</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Diluted</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">101,970,672</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">102,594,197</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">7</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.1in;z-index:2;min-height:0.1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Gyre Therapeutics, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Condensed Consolidated Balance Sheets</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(In thousands, except share and per share amounts)</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(Unaudited)</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:68.394%;box-sizing:content-box;"></td>
     <td style="width:1.44%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:12.362%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:1.44%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:12.362%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">March 31, 2025</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">December 31, 2024</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(Unaudited)</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Assets</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Current assets:</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">15,045</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">11,813</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Short-term bank deposits</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">14,846</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">14,858</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Notes receivable</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">2,138</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">4,373</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Accounts receivables, net</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">20,150</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">19,589</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Other receivables from GNI</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">230</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">230</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Inventories, net</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">7,878</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">6,337</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Receivable from GCBP</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">4,961</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Prepaid assets and other current assets</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">8,161</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">2,625</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Total current assets</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">68,448</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">64,786</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Property and equipment, net</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">23,518</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">23,880</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Intangible assets, net</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">5,083</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">273</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Deferred tax assets</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">5,818</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">5,619</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Long-term certificates of deposit</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">21,367</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">24,568</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Other assets, noncurrent</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">5,556</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">6,280</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Total assets</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">129,790</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">125,406</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Liabilities and stockholders' equity</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Current liabilities:</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Accounts payable</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">122</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">108</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Contract liabilities</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">28</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">61</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Due to related parties</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">228</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">227</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Accrued expenses and other current liabilities</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">17,239</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">10,615</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Income tax payable</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">569</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">2,831</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Operating lease liabilities, current</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">805</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">713</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">CVR derivative liability</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x2014;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">4,961</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Total current liabilities</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">18,991</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">19,516</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Operating lease liabilities, noncurrent</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">780</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">885</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Deferred government grants</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">905</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">928</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Warrant liability, noncurrent</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">3,413</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">5,668</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Other noncurrent liabilities</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">1,399</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">7</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Total liabilities</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">25,488</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">27,004</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Stockholders&#x2019; equity:</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Common stock, $0.001 par value, 400,000,000 shares authorized; 87,636,209 shares and 86,307,544 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">87</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">86</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Additional paid-in capital</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">138,179</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">136,185</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Statutory reserve</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">3,098</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">3,098</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Accumulated deficit</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(70,755</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(73,453</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Accumulated other comprehensive loss</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(2,486</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(2,597</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Total Gyre stockholders&#x2019; equity</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">68,123</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">63,319</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Noncontrolling interest</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">36,179</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">35,083</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Total equity</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">104,302</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">98,402</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Total liabilities and stockholders' equity</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">129,790</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">125,406</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.1in;min-height:0.1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">8</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.2in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Gyre Therapeutics, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Reconciliation of GAAP to Non-GAAP Financial Measures</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(In thousands)</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(Unaudited)</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:66%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:14.34%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:1.52%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
     <td style="width:14.14%;box-sizing:content-box;"></td>
     <td style="width:1%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="6" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Three Months Ended March 31,</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">2025</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">2024</font></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;">
     <td style="background-color:#caf0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Net income</font></p></td>
     <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">3,734</font></p></td>
     <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">9,935</font></p></td>
     <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Gain from change in fair value of warrant liability </font><font style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;font-family:'Calibri',sans-serif;position:relative;font-kerning:none;min-width:fit-content;">(1)</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(2,255</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">)</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(4,288</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">)</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;">
     <td style="background-color:#caf0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Stock-based compensation</font></p></td>
     <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">507</font></p></td>
     <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">11</font></p></td>
     <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Provision for income taxes</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">901</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">2,546</font></p></td>
     <td style="padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;">
     <td style="background-color:#caf0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Non-GAAP adjusted net income</font></p></td>
     <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">2,887</font></p></td>
     <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">$</font></p></td>
     <td style="background-color:#cff0fc;padding-top:0.01in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">8,204</font></p></td>
     <td style="background-color:#cff0fc;padding-top:0.01in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(1) Reflects adjustments for fair value of warrant liability based on the Black-Scholes option pricing model.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.2in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">9</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img51893664_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img51893664_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !G >H# 2(  A$! Q$!_\0
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MDDN(I]:UB[TS0[:4B&;45N7A@ESOVT/VK/#/[(/P1UOXF:O!;ZOXENY5\/\
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M1QDI*M# ^SM"&&Q,'555RM'#JE*-;6HK\&_VU_\ @OG\"OV$_P!HKQC^S?\
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MTS1[^U;Q==Z5J/B![;0=.OEN?JI555"J JJ JJH 55 P  .  . !P!P*6O\
M+OB[Q)S[C7C67&N>4\)C<12Q5.KE^4XVG+%Y/@<'AJKJ8/+8X.<XPKX.C*TZ
M]*K>GCZTJU3&TZRQ%:$_]R?#+PFX7\*> \%P'PO"MAL+2H-YEFT'"AFV<9E7
MIQACLWQ>)IQYHXS$\O+2=-VP.'C0PV$=.GAZ/+_+3\+_ /@UD_9O223Q'^T?
M^T]^T%\8/'.JZG>:]XGO?!S>#OAYH?B/7-6O;G4M<U#6G\1Z!\3O&VIWFKZA
M=37]_JG_  FECJEY?3W-W=7,T]P[U]@V'_!N+_P2KL[);2?X1?$75)@@234;
M_P".7Q32]F(8DR,NF^)-/L(W*D(?LUE FU00@D+.W[JT5ZV8^.GB_F=7VU?Q
M"XEP[O=4\KQTLEP\%TC#"Y1' X>,(K2,52Y8I)))'OX;P]X)PL7&GPQE%5O6
M53%X2&.K3E?F<YUL;]8JSFY:RG*;E)ZML_FY^)__  :\_P#!/WQ= \OP[\;_
M +17P?U)$E%JFD^.?#WC7P\TC[/+;4M-\>^$-<UZZC@VG9'8>+-(D?S'\Z>3
M$?E_C1^TI_P:_P#[8_PU@U#6_P!G7XB?#G]I+1[=)[BV\,7;)\(OB/(B@O%9
M6MMXHU6_\!:G<!,1"\N?'/AU+F8;Q86BL(U_O=HKZ/AOZ3'C'PW5IR_UJJ9]
MAH-<^"XEP]+-:=9)WM4QDE1S:*UU=',:3:LFVDD>1F_A-P'F\)*>24LOJRVQ
M&53E@:D-M53AS863]VW[S#SLF[6;;/\ (#^*OPB^*7P+\<:M\-/C+\/O%WPP
M\?:&P&I^$_&NB7NA:Q!$[,L5Y##>1HE_IER48V6K:=+=Z7?(/-LKR>/#G^C7
M_@WF_P""J.H_ +XF>'_V'/C9KX?X$_%KQ ]C\'-:U6XF*?"OXL^)-2\RT\,P
MRO(8+3P3\3M;OIX9(#&(])\>ZA8ZBCP6?B#7KB'^RW]J3]CO]G#]LWX?W7PW
M_:+^%GAOXA:,8+U=$U:^LXK?Q?X+U"]M9;4ZYX'\6VR)KGA7685EWI=Z7>0Q
MW&T0:A!>V;RVLG\ '_!5;_@C=\9?^";GB"/XC>#M5U[XH_LOZOK-I;>%OB[;
MP067BSX>:[=3*VC^&OB?;:.MO%I.L/=IY?ASQSH]I9^&M>NXK:(1^&_$%W9:
M!+_6/#GC!X?_ $C^'<9X:\9X*GPSQ+FE"V70J58U\'6S:E"?U3,.'\;45.=+
M,L/5;J0RS%<M7$4*E7!4J^84JN)B?B>9<"<3>$^;4.+>'\3/-\GPE3_;E&'L
M\33P$Y1]OA\PH1<HU<-4@K?6J.E*K"%>5/#RC39_I,T5^<O_  2>_:[N?VVO
MV$?@A\:]>N$E^(,6D7OP^^*J*"KGXB?#V^F\,ZUJTB>9*D:^+[6RT[QQ;11R
MN(+/Q-;6\@AN(9K:']&J_P Z<^R7'<.9WF^09G35+,<ES+&Y7C::=XK$X'$5
M,-5<)67/3E.FY4IKW:E-QG&\9)G]49?CL/F> P68X2?/AL?A:&+H2ZNEB*<:
ML+KI)1DE);QDFGJ@KPG]J+XJ7'P,_9K^/_QGLQ$U[\*/@S\2_B'8B?RS";[P
M?X.UC7K/S5E22-X_M-C%O1XY%D7*%'W;3[M7Q_\ \%!O!^I_$']A']LGP/HT
M;3:MXK_9A^.6@Z=$@+/)>:E\-O$=K BJK*Y9I)  $)D).(U9]JFN'J.$Q.?Y
M'A\?RK U\XRRCC>;X?JE7&T(8CF_N^QE._E<693K4LNQ]3#W^L4\%BIT.5<T
MO;0H5)4N5:7?.HV5]7H?Y1-I::SKU]:V%I]JUCQ%KM];V=L;B9I[[5==U:Y2
M"$SW%PY::[O]1N5,T\[L\L\S22NS,Q/^NC^SO\%/"G[.'P*^$GP'\$6T5KX7
M^$W@'PUX'TL1)L-V-"TR"TO-5N21OFO]:U!;O5]2NI2T]WJ%]<W5P[SS2.W^
M1UX:\0R^%]?\.>+;:'[3-X:UO1?$UO;A]GVB71-1M=6B@$FU@GG/:K'OVMMW
M;L'&*_V%=!US2_$VAZ-XDT.\BU#1/$&E:=KFCW\))AOM+U:SAO\ 3[R(D F*
MYM+B&:,D ['&0#Q7]U?3AQ&.AAO#C!Q<H995K<3XBI"#:IU,=AJ>1TJ#JP7N
MJ6'P^*Q"P[:34<1B5&ZYDOYQ^CM3H2GQ9B)I/')Y73YFESQH57CYU%&5KVJ5
MJ<742;5Z=-M+2\7B3Q#HWA'P[KWBSQ'?)IGA[PQHNJ>(==U*2*>>/3]&T6QG
MU+5+YX;6*>ZF2TL;:>=HK:":>18RD,4DA5#^5:?\%V?^"3KJKK^V%X6*NJNN
M?A]\9E)5@&!*M\. R\')# $=" :_1[XW^%M8\<_!;XO>"?#T4,^O^,/A?X_\
M+:'!<W"6EO-K'B#PIJVDZ9%/=2?N[:&2]NX$EN)/DA0M(_RJ:_S]8?\ @VR_
MX*CI%$C>"_@QN2-%;;\9M'*[E4 X)TL$C(X) )'4#I7\\^#/ OA/QAA,_J^)
M/'-7A"O@<1E]/*:5/-LGRWZ]1KT\5+%U''-,!C95?83I8>*E1=.,/:M34FXN
M/ZIQYQ#QKDE3+8\)<.T\]AB(8F6.E4PV+K_5I4Y4502EAL3AU'VJE5;4N9OD
M332W_KN_X?K_ /!)_P#Z/"\*_P#AO_C+_P#.XKZT_9:_;N_9,_;5?QTG[+_Q
MCTGXL/\ #1?#+>.%TSP_XRT(Z OC$^(!X:-Q_P );X<\/_:?[5/A;7_*^P?:
M_)_LZ3[5Y'FV_G?YL?[;?_!.3]IW_@GS=_#JR_:1T?P;I%Q\4K?Q+<^$E\(^
M,K+Q:LT7A.318]7-^;2VMC8%6U^P^RAPXN!]HP5,.&_HJ_X-*O\ C]_;_P#^
MO7]E7_T=^TA7ZUXD_1X\,>'?";._$G@OBS/^(88*.6RRVO/,<DQN3XQ8GB3+
M\BQ=YX')\-4J>P^L8F*]EB8<F)HI3YHQG"7PW"?BCQ?FG&^!X1X@R/+<JG66
M*^MTX4,=1QM#V65U\QH65?&UH1]HH4F^:G*]*HVK-IKV/_@Z3_9#/B[X1_"/
M]M3PS8*=6^#VHQ?"7XI3Q6ZF6X^'GCS6HG\":G=W2KYBP>&/B)?7&C6L,A,+
MS?$B9P\4D2I<?EQ_P;0?M5)\%?VW]>^ >NWGV?PC^U=X-&@6?F,_DP_%#X8P
M:YXL\#N^95A@CU+P[J'Q!T,NL3S76J:AH-MD1KNC_NB_:1^!OA3]ICX!_%_X
M >-XM_AGXM^ /$G@C4)U5&GTR76=.F@TS7;+S(Y8TU+P]JOV'7-+E>*5(=1T
MZUE:*54,;?Y3LD?Q3_8\_:5,<JMH'QG_ &7_ (WC/^O@AL_B#\'?' 971@8Y
M9M*N-:\/B2*1&,.H:3<+)&\MM<JS_8?1\Q]#Q6\$N-?!_-*T'CLJPV(I95.L
MT_9X',JD\QR;$6?O5%E'$6&G4J>]RPH2P-!<D;'A^)^&J<%^(/#O'F#IR6%Q
MM>DLP4$TI5L-&.&QM.Z:C&6,RNI:%VN>K3K3?-[Q_KG5_%-_P=3_ +3QUGQ]
M^SM^R!H&IHUEX,T?5OCI\2;"+<^_Q!XF,_A'X96T\@"I#-I.A6/C[4)K0M*\
MT/B;2;N1+=8K9[K^N_X"?'+PA\??@!\*OVAO#-RL'@[XH_#/PQ\2K1[DK&VE
M6.O:#;:S>6.H /(L%WH<LMSIVIQ>9)]GN[*YB+OY98_Y>7[>_P"T1JO[97[;
M/[0?QTL([K6;?XE_%35-/^'%A91W5W>77@/0IX/!'PJTZTMF,UQ)J-[X/T7P
MZ9K2W7RY-7O+E;."**2*%?S+Z)7 E?,/%',LZS3#2I4N ,'BW6IUXI*CG^.E
M7RK#8>NIKEC.A0CFV)3;O2Q&#I35FDU]=XV\1PPG!N'P&#J1J5.)Z]"E2E"6
ML\OI*GC*U2FE[S523PE)Z*+IUY)N[49?T;_\&KW[)QOO$7QZ_;3\3:5(+?0[
M.W^ OPGO+A#Y,VH:H;#Q7\5=6M$D4*9;&SMO F@V6H0%SC4_%.F[XRMS')^Q
M?_!Q!_RB<_:&_P"QE^!/_J]OAW7VS_P3C_99L_V,OV*OV?\ ]GU;6"W\0>$_
M!%KJOQ!F@PYO_B=XRN+CQ?\ $2Z:YYDNX8_%FMZI8:9+*Q,.BV.FV4*PVMK;
MP1?$W_!Q!_RB<_:&_P"QE^!/_J]OAW7SF+XW?B!])_ASB*G5=7+I>)7"F79+
MJ^19-E>>X#!8&I3BV^18R%*6858)M+$8RLTW>YZV'X>7#'A#F>5."CB8<)YQ
MB<=HDWCL7EN)Q&)4FDN;V4Y_5XR:3=.C"]K'\!7[(/[2?B#]D']H3P5^T;X0
MTRSU;QC\-M*^(LW@VTU*%;C2HO%_BKX8>,_ WAG5=7M3+";W2M UKQ/9:]J.
MG1S0S:G::9+IT4]M)=+<P_0'[+/_  3O_;O_ ."E?BOQ5X^^%?@;6/&]IK'B
MC5M0^(7QY^)OB*W\.>#9_%FI7+:AK=SJ7BO6&EU/Q7K\][=F74K#P?I'B74[
M*6X1[^SL;4&6/YA_9<^!6K?M._M'_ []GK1+J?3[WXQ?$[PCX#FU6V2.2?0M
M'UK58(_$?B-(Y8YHW_X1OPXFJZ\R/!.K)IS*8)L^4_\ J_\ P>^$7P\^ GPO
M\#_!OX4>&M/\(?#SX=^'[/PWX6\/Z;#'#;V=A:!FDFF,:(;K4M2O);G5-8U*
M<-=ZKJ][?:G>RS7EW/*_]>_2$\8Z/A!B<#5X>RG+L=QWQ-EE/#2QV8PJU*&7
M</95B\;4PLJM*C5H5:\JN89CC_J=&-:G1=2GB*V*=6-"A0J_A?A9P'/CG"XB
M&;8W%4.&LHQU2M#"862ISQ>:8RAAHUFJDX3A"%/"X7#QJSY95$IPA2]FZDZB
M_+O_ ((G_P#!/OXR?\$Y?V:_B?\ "'XV^(/A]XB\3>./CSJ_Q5TVY^'.J:[J
MVDVFAZG\,OA;X/2PU"XU_P .^&[A-6AU;P5JTDD=M:W5FUC-8S)>&:6>VMOY
M2_\ @O;_ ,%,_%W[7'[1WB[]G#P!XFN+7]F#]G[Q=<>&[32--F>"R^)GQ4\+
MM/IGBKQYXB*-C5+'P[KAU;PUX%LY'DTZWL=/N/%$,?V_7E^P?WQ?M!^-;_X;
M? 7XV?$/2]_]J>!/A+\1O&.FF,JKC4/#7A#6-9LBC.K(&%S9Q$%E901DJ1P?
M\BG2GTZZU#3)?%!U.]TBYO[*7Q(=.GC36KS3)KF)]:-A=7;-$NK7-HUT;6XN
MF:-;V2.6=BH<G\D^BWEW_$1>.^.O%OBRCAL?GF J9?# PI86G&A1S/,J.(>)
MS##89R<:6*PV$P%'#X1\S47C<14BXU84ZD/N?&3&RX6X;X:X*R:M6PF7XN-:
MGB*DZK=5X#!.C"EA:M5*+G2G4Q#J5[V<EAZ<9.4933_I<_X);_\ !O)K7[8G
MPF\/?M%_M0?$7QE\&_A1X[MAJ?PU\%?#VST!/B?XR\,2F-K+QQ>ZYXLTGQ+H
M'A'P_K*B63PY97'A37M5US3##KC#2M.NM-;4?N+]J7_@U=^'-E\.-:US]C;X
MZ?%2]^)^D6<M_IO@3X^:CX"UGPSXSDMH9G.@Z?XJ\&^!?A_<^#]3U B)+#4]
M9M?$6D"\ M]0&F6-R^I:;U>D?\'4_P"S%X?TK3-!T/\ 8]^-FF:+HFGV6D:/
MIMGXH^'%O::?I>FVT5GI]C:P)J!2&WM+2&&"")"5CBC5%X45H?\ $5[^SM_T
M:5\=/_"M^'7_ ,GT9OFGTQL;Q/7S[+\BS/+,O6-E5P/#L*O#%;*J.!C4O2P6
M*ISQ?M<8Y4;0Q.*J58XF<Y5*E"IAK4XTJP."\!L-D]/+,3F.68S$?5U3Q&:3
M68QQU7$2C'VF(I5(TOW'[R/-1I07LZ<?<E&:G5]I_*;^QY^U7\;_ /@G'^U7
MH?Q7\*V^M:%XG^'WB>\\'?%_X8:H]QID7C'PSI^JRZ7X[^&?B_32Z1_;()+>
M]_LJ:[29O#7B^PTS7+96FT_9+_J9?"WXD^$?C)\-? 'Q;\ :D-8\#_$WP;X:
M\>^$=4">6;_PYXLT>SUS1[F2+<YAFEL+Z!IX&9F@FWPN=R&O\L/_ (*!?M$?
M#?\ :S_:]^,O[1_PK\!^(/AIX8^+FKZ-XHN?!WB6[T>]U*P\3KX9T72O%=^9
M]#+6!B\0Z[IMYXB?$DL[WFJWDMP^^78G]Y/_  ;V?$&_\??\$KO@+%J=P+BY
M\!:W\4?AS%@Y:#3?#?Q$\02:);,QRQ,&B:AIR*&)V1[(TV1)'&G3]+GA>&9<
M%<#^).+RA9+Q-*IE^2\08.].=:FLSRO$9C'!8JM2<X8B>38[!XK"4*\)M3IX
MJHN><%14.?P/SF6%S[B/A'#XYYCD])8C,,KQ.JA)8;%T\+*M2A)J4(XVA6HU
M9PY=)44[1;ES?M?1117^?Q_3(4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110!^.W_!=;]K.[_9,_X)W_ !3U+PWK,NB_
M$;XUW>G_  #^'=Y:7-Q:ZE9ZEX[M-3N/%>KZ=-:CSK:]T3X<Z+XRU*PO3);Q
M6NK0Z:3,T\EO:W/XY_\ !IKXMMCIG[:_P^5E2XL]0^"/C%(C@%[;4;/XAZ"6
MB&02D$FC*LH 8(9X-QCWH).(_P"#L#XHW%QXX_8]^"=O='['I?A;XF?%75[+
M9@?:];U70/!_ANZ\P$>81!H?BR$HX;RMP:,KYTH?X _X-O/V@;3X-_\ !1W1
M/ .LWJ66A_M'_#?QA\*4>=BMJ/%VE1VWQ%\(&5RRI'/>/X0U?P]I[.&:74/$
M%M91 27@S_>G"7AU&?T0.*\5AL/S9MQ%'%<85IJ-ZKPO#.<494:"LE*5*&69
M+B\31IZVJXZM.+:G8_F_.N*G'QTR7"U:C6#RR%/)(1O%0]OFV"G*=1MMV;Q.
M+P].<O=ERT(JUE[WU[_P4*\&7/@3]M7]HW1;F%XEO_B1JOB^TW1B-9;'QY%;
M>-+:2+:%62-5UYH/,&2TD,@D9I5D-?TS_P#!*#X*6?P?_8V^'^IM;-'XA^,!
ME^+?B"XEC19I8O$UM:0^%H$8-(PLH/"%AH<UO"7""YO+Z[$,$][<)7YL_P#!
M<_\ 9YOK;Q'\.OVF=#LY9-)U;2H/A7X]D@0-%8:OITVIZQX,U>Y1(3(#J]C>
M:SHES>3S?9XVT30+%$CGNT^T?T-_#K0K3PO\/O OAFPB2"Q\.^#O#&A64,:J
MB16NDZ+96%O&B*S*JI%;HJJK,   &(Y/R/C/XC?ZQ> _A'A,'B+_ -L<U#.X
MTY^]]>X,P&$RW$X;$16L8U<9CJ684Z4]'!86LKQ=.3_ ?HY>#ZX0^E)](#,,
MPPB3R#V6)X9G4I-065^(N9X_.<+B\')N4)2H8'+*V45:T'S1G]=P[Y6ZU-=E
M117/^*_%GA?P)X:USQEXU\1:+X2\)>&=-NM8\0^)?$>IV>C:%HFE649EN]1U
M35-0F@L[&SMXU+2SW$T<:C&6R0#_ !Y3ISJSA2I0G4J5)QITZ=.+G.I.;480
MA"*<I3E)J,8Q3<FTDFV?Z&RE&$93G)1C%.4I2:C&,8J[E)NR223;;:22NSH*
M*_$_Q;_P<,?\$I/">O:CX?'[0>O>*)=+NI[*YU7P=\'/B]KWAZ:XMG,<ITS7
MH_!<.FZW9EP?L^J:-/?Z3>Q@3V-]<P/'*^-IW_!QA_P2EU#4;#3V^-OC?3EO
M[VTLFU#4_@=\7;;3; 75Q' ;W4;E?",K6UA:^9Y]Y<"*3R+>.278VS!_0X>$
M'BM.E&M'PWXX=.4%4C+_ %7SE7@TI*23P:E9Q::TNTU9:H^:?&G""FX/BC(.
M92Y6O[6P+]ZZ5KJO;=I;V/W)HK\__B)_P4R_94^%;>')?&>O^,K/2?&FBV_B
M7P-XITOP)K_B3P7X[\-7<4%Q:>(/!7C/PY!JOACQ1I,]O=6LYN=&U6[^S+=0
M1WJ6T\@B'':'_P %>/V$-:U&WTZ3XJZUH9NI8X(K[7?ASX^M--265PB"YO+;
MP_>1V4.XCS;N\%O96Z9EN;F&%'D7DP_A?XCXS!PS#!\"\68S!5(2J4\5@\AS
M+%4*L(-QG*E4P^'J1J*$HRC+D<N6491=G&27S..\9_"/*\QJY/FGB9P+E>:X
M>K&CB,NS+BC)\OQN'K3C&<*>(PV,Q=&K0G*$X2C&K"#<9PDM))O],:Y#Q_X
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MTO7TAD#7MCX-_P"$ U?Q#:Z7=(;%]6U[2=8DBGO]'TJ>P_M8K^3_ /X.3O\
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M*3U;;/8ITX4H1ITH0ITX)1A3IQ4(0BMHQC%*,4NB2204445D6%%%% !1110
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M\1P^%;2^DTRYUUK*Y\5?\2^&_BTS69+1Y0Y(F32KXKMQ]G;.1]!?\/P_%?\
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MYKE;*X\M5BP1&Q+#&#^T1_X*7?L, $G]HOP;@ DXL_$K' &>%70BQ/H "2>
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M/#6CZAIEMXA\4^)==L'FTJVCL-(&FVEG?W&HQ:E<WMM!92?H3_P3;_9FU_\
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MC\<?$O"9GA)>[6PM6MFT,30<Z;M-4Z]&HI4:EN2IRU%!MTYV*_G4_P"")?\
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M_P#"OO"_AFV2>.";4?$GQ%\'M9P[U#>:\?AC4_$VH-$B\N(;"67LD3]OT/\
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M]ARU_:J^%O\ PFG@JSM+;XY_"_3KV\\*W;S6]@/%_AR/S+W5/ >IZA<S6UK
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MJ$JW.KZYJVH7,M]K.OZS=(D2W&I:MJ$\US*(HX;2TB,&G:=;VFFV=G:0%%?
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9&I&$\;F.,E&"K5O9TX*%.G"G2IP@HG__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>gyre-20250509.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-05-08T17:47:50.2460+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.gyretx.com/20250509" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:gyre="http://www.gyretx.com/20250509" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" namespace="http://fasb.org/us-gaap/2024"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.gyretx.com/20250509/taxonomy/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:roleRef roleURI="http://www.gyretx.com/20250509/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="gyre-20250509.xsd#DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://www.gyretx.com/20250509/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="49.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="50.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="51.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="52.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="53.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="54.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="55.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="56.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="57.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="58.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="59.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="60.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="61.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="62.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="63.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="64.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="65.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="66.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="67.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="68.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="69.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="70.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="71.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 09, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  09,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-51173<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Gyre Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001124105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">56-2020050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">12770 High Bluff Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">567-7770<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GYRE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>7
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( ,2CJ%I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( ,2CJ%JD_\;P[@   "L"   1
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MM5II ,,X?<D3$L/<@HL(2W@4R]9<X%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A
MT%116F]?(+3E'S/X%<M4C66C 1-702:YB+3R^6S%_-K>/F7/Z3H=,H%N,!M8
M('_.;Z?D3EJ(X53"Q,!J9S]6:\?1TDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\
M]L3MGXS*VG0T;1K@X_%X.+;+THMP' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1
MIJJ-4T_3]WW?ZYMHG J-6T_3:W?=TXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]
MKFNDZ19H0D;CZWH2%;7E0-,@ %AP=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1
M_L;%!-9ITAF6-$9RG9 %#@ WQ-%,4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'
M@B'%W*_]]9>[R:0S>IU].LYKE']IJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ
M^R-;88<G;CL3<CH<9T)\S_;VD:4E,L_O^0KK3CQG'U:6L%W/S^2>C'(CN]WV
M6'WV3T=N(]>IP+,BUY1&)$6?R"VZY!$XM4D-,A,_")V&F&I0' *D"3&6H8;X
MM,:L$> 3?;>^",C?C8CWJV^:/5>A6$G:A/@01AKBG'/F<]%L^P>E1M'V5;S<
MHY=8%0&7&-\TJC4LQ=9XE<#QK9P\'1,2S90+!D&&ER0F$JDY?DU($_XKI=K^
MG-- \)0O)/I*D8]ILR.G=";-Z#,:P4:O&W6':-(\>OX%^9PU"AR1&QT"9QNS
M1B&$:;OP'J\DCIJMPA$K0CYB&38:<K46@;9QJ81@6A+&T7A.TK01_%FL-9,^
M8,CLS9%USM:1#A&27C="/F+.BY 1OQZ&.$J:[:)Q6 3]GE[#2<'H@LMF_;A^
MAM4S;"R.]T?4%TKD#R:G/^DR- >CFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX
M"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_+GW/I>^Y]#VATK<W(WUGP=.+6]Y&;EO$
M^ZXQVM<T+BAC5W+-R,=4KY,IV#F?P.S]:#Z>\>WZV22$KYI9+2,6D$N!LT$D
MN/R+RO JQ GH9%LE"<M4TV4WBA*>0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/
M^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KTL<QP3A[+##MG/)(=MG>@'37[]EUVY".E
M,%.70[@:0KX#;;J=W#HXGIB1N0K34I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OG
MP5&PH^\\EAW'B/*B(>ZAAIC/PT.'>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@
M9& MH >#KU$"\E)58#%;Q@,KD*)\3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB
M4CG":9@39ZO*WF6QP54=SU5;\K"^:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB
M\QE3ON<K2<15.+]%,[82EQB\X^;'<4Y3N!)VM@\",KF[.:EZ93%GIO+?+0P)
M+%N(61+B35WMU>>;G*YZ(G;ZEW?!8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(
M3)QYQ1$!=$4"(Y4<!A87,N10[I*0!A,!S93)1/ "@F2F'("8^@N]\@RY*17.
MK3XY?T4L@X9.7M(E$A2*L P%(1=RX^_ODVIWC-?Z+(%MA%0R9-47RD.)P3TS
M<D/85"7SKMHF"X7;XE3-NQJ^)F!+PWING2TG_]M>U#VT%SU&\Z.9X!ZSAW.;
M>KC"1:S_6-8>^3+?.7#;.MX#7N83+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!
M()O\UMND]MW@#'S4JUJE9"L1/TL'?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8
M\PRA9CC?AT6:&C/5BZPYC0IO0=5 Y3_;U UH]@TT')$%7C&9MC:CY$X*/-S^
M[PVPPL2.X>V+OP%02P,$%     @ Q*.H6HXK>TY5!   (1$  !@   !X;"]W
M;W)K<VAE971S+W-H965T,2YX;6R-F&]OXD80QK_*RI5.K90$K\._I(!$(,E%
M=\EQ@?;45GVQV&-8Q?:ZZW4(W[ZSAM@T-6/>@-=X'O]V=OR,E\%&Z9=L#6#8
M6QPEV=!9&Y->MUJ9OX989!<JA01_"96.A<&A7K6R5(,(BJ X:GFNVVW%0B;.
M:%"<F^G10.4FD@G,-,OR.!9Z>P.1V@P=[KR?>):KM;$G6J-!*E8P!_-;.M,X
M:I4J@8PAR:1*F(9PZ(SY]8W7L0'%%;]+V&0'Q\Q.9:G4BQT\!$/'M400@6^L
MA,"O5YA %%DEY/AG+^J4][2!A\?OZG?%Y'$R2Y'!1$4_9&#60Z?OL !"D4?F
M66T^PWY"!:"OHJSX9)O=M>VVP_P\,RK>!R-!+)/=MWC;)^(@P#L6X.T#O()[
M=Z."<BJ,& VTVC!MKT8U>U!,M8A&.)G859D;C;]*C#.CJ?)S3+)A(@G8;6*D
MV;*'9+?:F+5!R^!-[*4M?R]XLQ/TC@@^BBUSK\Z8YWJ=_T:W$*WD\TH^KY"[
M/"(W4:^@V5_C968TKN#?=4 [A7:]@BWKZRP5/@P=K-L,]"LXHT\_\:[[*\%W
M6?)=4NI5_A;;%.K@Z/#^^1<"HEU"M$F5,1($!<5=)%9U%'1\**(,"(Y.R=$Y
M+1DST%+9>@H85F5M7F@E6T5%&3754;=$ZY*"^]*^DQ&PISQ>@JZ#HC5<USWO
M<-Z[)'AZ)4_O%)YG6$E;V9BS)Q'7)HK6N=]J8(LU:)%";J2?G>'CZU\0A/V2
ML'\*X0374XL(50-X8U]@6\=(*V'>./?:W*46\JK$NCH%"R>I=*ITX5)G;&ZP
MS)C2;*)RY$5L%=1FDQ:?WA*$W*T\U3V%<2'>V$. ^9.A] M0HO0:)#O=<WP2
M7+?C4H0'KL]/(1P' 5HBULS^@'W%Z]BWI#9U#9+<Z_5<]AF[(+N)\C!D4XW]
MEJ*M>@ G+9RF76Q4+2TM.<\E%@RGTUDU 4[;^$? B1UA-2[4IKZ%TG)SD;"I
MA)6BX*KFP&EW_PA7/BLSK5YEXM<O-JTY&5-H5;_@M,U_1)NIS*#7_"G3HP]P
M@^*5QR_)-:T:!J?=OEC#,;[I'D>A!?J=/@52=0I.6_Q7Y6-.9FN54*VK0:33
M[9WW\ &EB*K.P&E#7TB#;52%C'L_+W]A<_!SC=FJQ:*5)BJ.T1;G1ODO%%K5
M'3CMX LM IFLV'P;+U542T0+W/_Q3#4!KVH"'NW8[UEAMV_^6B0K.-KA&X2>
MQO/I^#O%5-F^=Y+MW\:@5S9+]ZA@UEC@<2J2VO5K$&QZ<_0.WO-I0_Z!N3*0
M6)8X3_;],JM%HH4:D2I7]QIL6$72E\8FZA$M4TM16U -*HT\E9%[M.G.-)S[
MF!Y S][M.?"U'W='W\*PWA,:]!K)*A_W:-?]']E#EN5(U@A(RQX%;!UL>.V?
M!X_"UG/&(@A1R+WHH:[>[<=W Z/28@^\5 9WU,7A&@2RV0OP]U I\SZPV^KR
M7Y'1OU!+ P04    " #$HZA:GZ ;\+$"  #B#   #0   'AL+W-T>6QE<RYX
M;6S=5VUKVS 0_BM"/V!N8FKBD1BV0&&PC4+S85^56'8$>O%DN7/ZZZ>S;"=I
M=67=A['-H<G=/;J[1W<GF:Y;=Y+\X<BY([V2NMW0HW/-^R1I#T>N6/O.-%Q[
MI#)6,>=56R=M8SDK6W!2,EG>W&2)8D+38JT[=:=<2PZFTVY#;VA2K"NCSY:4
M!H-?RA0GCTQNZ)9)L;=B6,N4D*=@7H+A8*2QQ'DJ?$,78&F? KP(&K <XRBA
MC05C$C*$[_VX_!DP::U7A90SP24-AF+=,.>XU7=>&18/QA<0&>7=J?$,:\M.
MB^4M/3L,/S[)WMB2VSG-@DZF8BUY!72LJ(_PZTR3 .B<45XH!:N-9@.'R6,4
M?-@#E_(!6OBMNHK=5R3TXE,);2"PU4GTA$8QA D*Q+^,%F)?A+W]K;"D$8_&
M?>S\;O2@?^^,X_>65Z(?]+Z:\V/1%WATUC3R]$&*6BL>]O[+"8LUF_S(T5CQ
MY+/!I!R\@5M*'KEUXG!I^6%9L^.]FZ:IKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7
M^2V,D_'T7!S1JP,Z6PE<A!OZ%>Y7>>9 ]IV03NA1.XJRY/K%.?7A'=O["_PJ
MOE]?\HIUTNUF<$//\A=>BD[E\ZI[J,NXZBQ_AOMHD<VWL,\E=,E[7FY'U=;[
M021>\%G'!QR>(W?#$T<PGX#%$<"P/!@#S"=X87G^I_VLT/T$#..VBB(KU&>%
M^@2O&+(=/EB>N$_NG_A.\SQ-LPRKZ'8;9;#%ZI9E\!>/AG$##RP/9'I;K?%N
MXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q _G@>F*FX3YI"
M5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"IQ%', ;  4/2
M='@//GL?)=-[*CG_5U/\!%!+ P04    " #$HZA:EXJ[',     3 @  "P
M %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=
MOZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'
MTD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[P
MS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T
M>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( ,2CJ%H<.&7J/P$
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M?P%02P$"% ,4    " #$HZA:1L=-2)4   #-    $               @ $
M    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( ,2CJ%JD_\;P[@   "L"
M   1              "  <,   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0
M   ( ,2CJ%J97)PC$ 8  )PG   3              "  > !  !X;"]T:&5M
M92]T:&5M93$N>&UL4$L! A0#%     @ Q*.H6HXK>TY5!   (1$  !@
M         ("!(0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0
M   ( ,2CJ%J?H!OPL0(  .(,   -              "  :P,  !X;"]S='EL
M97,N>&UL4$L! A0#%     @ Q*.H6I>*NQS     $P(   L
M ( !B \  %]R96QS+RYR96QS4$L! A0#%     @ Q*.H6APX9>H_ 0  / (
M  \              ( !<1   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M ,2CJ%HD'INBK0   /@!   :              "  =T1  !X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( ,2CJ%IED'F2&0$  ,\#   3
M              "  <(2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )
-  D /@(   P4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="gyre-20250509.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gyretx.com/20250509/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="gyre-20250509.htm">gyre-20250509.htm</File>
    <File>gyre-20250509.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "gyre-20250509.htm": {
   "nsprefix": "gyre",
   "nsuri": "http://www.gyretx.com/20250509",
   "dts": {
    "inline": {
     "local": [
      "gyre-20250509.htm"
     ]
    },
    "schema": {
     "local": [
      "gyre-20250509.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://www.gyretx.com/20250509/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gyre-20250509.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gyre-20250509.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.gyretx.com/20250509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.gyretx.com/20250509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.gyretx.com/20250509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.gyretx.com/20250509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.gyretx.com/20250509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.gyretx.com/20250509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.gyretx.com/20250509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.gyretx.com/20250509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.gyretx.com/20250509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.gyretx.com/20250509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.gyretx.com/20250509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.gyretx.com/20250509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.gyretx.com/20250509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.gyretx.com/20250509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.gyretx.com/20250509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.gyretx.com/20250509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.gyretx.com/20250509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.gyretx.com/20250509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.gyretx.com/20250509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.gyretx.com/20250509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.gyretx.com/20250509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.gyretx.com/20250509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.gyretx.com/20250509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0000950170-25-067452-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-25-067452-xbrl.zip
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M(TB'U\#*(Y:A)C%@6+VLI/[B,Z1;U7@K&-L+V=_RP3=='?6L#W.":EDHR+M
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M*_.VZ"3O(['G^ ,6L.M$(TZR:Q_@I-2>#<:Z[B.!DY["?*K<&\O<-R_QX=$
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M;RC':($7KSY15C<0#.XM?7C(P,?%O%JP*)FC; ,%F</!:%?K2>),XGP@<;Y
M[E;,#B[,3(3H%\I_Y[+&KWD,HCT.YOQ*ZT$0<?SE$P^=J=)%%ALGTL-0%TBK
MDFEQ!9H2WBD2Z-\H&=.J$.@C4,]&<Z'N$\41L3ZQ_H%8_S,@LP ?7([!PL+
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M!?-K>(=KT"[%M#.7H^P:9$*I'8/678X!QJQ1Q>0% J!^P'J>!WJ+4<DOT*[
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M3+[5_0;IL: "V5<ALE%L 5#8DT5'^0V/!Q0I_57T.U;GP-)Y<'@^U7SMBHJ
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M#+O^%1+-=]<_CZ9!XFWXW+GC8^YO>)C-Q^J56/\\K?I8_T)'A39<*,7=]6\
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MF5I$TLMM-I &.P7ENP%I5V/1-O(#$7<7Q 5Q@)O[O[SHO]@)H7//*'.8T?Y
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M\?9;R&//\;5.X]1"_O'YE3VVD'_]\SAP%W_[C]<_3^.9][?_#U!+ 0(4 Q0
M   ( ,2CJ%IB)&?U$A0  /7/   1              "  0    !G>7)E+3(P
M,C4P-3 Y+FAT;5!+ 0(4 Q0    ( ,2CJ%JOAACKT @  (=E   1
M      "  4$4  !G>7)E+3(P,C4P-3 Y+GAS9%!+ 0(4 Q0    ( ,2CJ%I#
M>T,MSS0  +RX!  /              "  4 =  !G>7)E+65X.3E?,2YH=&U0
52P4&      ,  P"[    /%(

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>gyre-20250509_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="gyre-20250509.xsd" xlink:type="simple"/>
    <context id="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124105</identifier>
        </entity>
        <period>
            <startDate>2025-05-09</startDate>
            <endDate>2025-05-09</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8"
      id="F_408bd495-aed1-4cdc-9f01-7c772fba48c6">0001124105</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8"
      id="F_5b0fd738-f774-4f82-9278-c40bd29ab481">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8"
      id="F_6802a9a5-28d5-4388-bfd6-423bf670d6c8">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8"
      id="F_02eb8609-ad8b-43c5-8d4a-e6752afe031b">2025-05-09</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8"
      id="F_f88903b5-5d31-476f-8ba6-5e291b591e93">Gyre Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8"
      id="F_d61d0191-d9bc-48e7-8470-7b00f11d11ad">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8"
      id="F_e3e31129-b729-4d63-8e95-848547b85274">000-51173</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8"
      id="F_5f3f5439-f7ae-4f70-be5c-de92c5a407e2">56-2020050</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8"
      id="F_790e36d5-2387-46f2-b99c-eeb9cec19f33">12770 High Bluff Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8"
      id="F_2f5e3a25-b103-4df9-810b-e751c7946955">Suite 150</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8"
      id="F_129d2718-6ad8-4a68-ac1e-61a58dd7cbde">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8"
      id="F_51746b77-19b4-4118-80d8-d678c57d4504">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8"
      id="F_ec73bce0-ff2b-47dd-8892-70d81a0df8ba">92130</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8"
      id="F_b6be4f22-475f-453f-85de-198a80ac72aa">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8"
      id="F_0ac9ebe2-12b4-49ae-bb3c-cb9ee1d741b5">567-7770</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8"
      id="F_9230b81d-b476-4394-af20-0824faf1034c">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8"
      id="F_37c18f17-1973-4170-8d3a-47bc29acb22f">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8"
      id="F_2221bb99-9c1c-4440-b287-a8fee03354ee">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8"
      id="F_a4d1ec79-eed7-4155-b92f-cdfc677c0460">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8"
      id="F_da8708c9-9c69-4716-9fea-7ae3079fa6c6">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8"
      id="F_c44f9a91-bec7-4081-b25d-4d959a1bc0d6">GYRE</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8"
      id="F_8da4383c-0893-431d-ac59-52d87f260bfd">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_ed55c1b5-14af-48cc-b303-dc9aaea4c5d8"
      id="F_c849c9ef-5695-40ca-8061-b371c8a2a332">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
